HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Dopamine in patients with cardiogenic shock (author's transl)].

Abstract
The effect of dopamine was tested in 20 patients with cardiogenic shock. 14 patients suffered from acute myocardial infarction, 6 patients from severe heart failure. In the beginning the dosis of dopamine was 200 to 300 microgram/min. 4 patients with an acute myocardial infarction died in shock. The remaining 10 patients survived the first shock symptomes. All patients with heart failure survived the cardiogenic shock. Hemodynamic studies showed a sigificant increase of the arterial mean pressure and a decrease of the diastolic arterial pulmonary pressure. During dopamine a statistically not significant increase of cardiac index and stroke volume was observed.
AuthorsD Kikis, H Esser, G Trübestein
JournalMedizinische Klinik (Med Klin) Vol. 72 Issue 28-29 Pg. 1212-7 (Jul 15 1977) ISSN: 0025-8458 [Print] Germany
Vernacular TitleDopamin beim kardiogenen Schock.
PMID329088 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Dopamine
Topics
  • Aged
  • Blood Pressure
  • Cardiac Output
  • Clinical Trials as Topic
  • Dopamine (administration & dosage, therapeutic use)
  • Drug Evaluation
  • Heart Failure (complications)
  • Humans
  • Middle Aged
  • Myocardial Infarction (complications)
  • Pulmonary Artery
  • Shock, Cardiogenic (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: